A clinical study to evaluate efficacy of eplerenone, a new drug for the treatment of acute heart failure while protecting myocardium (a randomized, double-blind, placebo-controlled study)

Trial Profile

A clinical study to evaluate efficacy of eplerenone, a new drug for the treatment of acute heart failure while protecting myocardium (a randomized, double-blind, placebo-controlled study)

Recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Acute heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Mar 2017 Planned End Date changed from 30 Sep 2017 to 30 Jun 2018.
    • 31 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top